E levated circulating levels of total cholesterol (TC), lowdensity lipoprotein (LDL)-cholesterol (LDL-C), and triglycerides, as well as decreased levels of high-density lipoprotein-cholesterol (HDL-C) are associated with increased risk of cardiovascular disease.
improve long-term risk prediction of adult hypertriglyceridemia from childhood serum triglycerides level. 8 Moreover, a longitudinal study showed an average increase of 0.3 mg/dL >3 years in triglycerides levels per 1 SD increase of a triglycerides GRS. 9 Interestingly, a GRS of 95 known lipid loci was associated with increased baseline carotid plaque, and LDL-C and TC scores were additionally associated with incident myocardial infarction and cardiovascular disease. 10 Findings of a GRS based on 32 lipid-associated SNPs in a lifestyle intervention study of 2993 participants suggested that a high genetic burden predicts an attenuated response in LDL-C levels to both dietary and physical activity intervention and hence individuals in low genetic risk might benefit more from lifestyle intervention. 11 Identification of interactions between GRS and lifestyle factors may provide novel insight into the nature of dyslipidemia and may serve to identify individuals who are at higher risk of dyslipidemia and who may benefit from genotype-based targeted intervention. At present, it is unclear whether and how the identified genetic susceptibility loci collectively interact with lifestyle-related risk factors to influence risk of abnormal lipid levels. Hence, we constructed 4 cumulative weighted GRSs (wGRSs; 74 TC loci, 58 LDL-C loci, 71 HDL-C loci, and 39 triglycerides loci, respectively) based on validated lipid loci to examine the combined effect of multiple SNPs on fasting serum lipid levels in the general adult population. Moreover, we aimed to test whether the effect of lipid wGRSs may be modulated by lifestyle behavior (represented by diet, alcohol consumption, smoking, and physical activity) or individual metabolic health status (represented by body mass index [BMI] , waist circumference [WC] , and insulin resistance estimated using homeostasis model assessment of insulin resistance [HOMA-IR]).
Methods

Study Populations
The discovery study was performed using the population-based Inter99 cohort (ClinicalTrials.gov; ID-no: NCT00289237), 12 which is a randomized nonpharmacological intervention study of prevention of ischemic heart disease initiated in 1999 at the Research Center for Prevention and Health in Glostrup, Denmark. A random sample of 13 016 individuals living in Copenhagen County from 7 different age groups (30-60 years, grouped with 5-year intervals) was drawn from the Civil Registration System and further prerandomized into high-intensity (90%) and low-intensity (10%) intervention groups. A total of 6784 (52%) attended the baseline health examination and for genetic studies all individuals with non-North European ancestry were excluded. Genotypes are available from 6377 participants. Individuals receiving lipid-lowering medication were excluded before analyses (n=80). All analyses were conducted on baseline measures before the lifestyle intervention program.
The replication study comprised individuals from the Health2006 cohort, which is a population-based epidemiological study of general health, diabetes mellitus, and cardiovascular disease of individuals aged 18 to 74 years conducted at the Research Center for Prevention and Health in Glostrup, Denmark. 13 The participants in the Health2006 cohort were drawn as a random sample from the background population living in the south-western part of the greater Copenhagen area. A total of 3471 patients entered the study and participated in a health examination between June 2006 and June 2008. All participants were Danes by self-report. Genotypes were available from 2883 study participants. Individuals receiving lipid-lowering medication were excluded before analyses (n=238). Written informed consent was obtained from all participants, and the study was approved by the Scientific Ethics Committee of the Capital Region of Denmark (Inter99: KA98155 and Health2006: KA-20060011) and was in accordance with the principles of the Declaration of Helsinki II. Baseline characteristics of the Inter99 and Health2006 participants are shown in Table I in the Data Supplement.
Biochemical and Anthropometric Measures
At the baseline, health examination body weight (kg) and height (to the nearest 0.5 cm) were measured in light indoor clothes and without shoes. BMI was defined as body weight in kilograms divided by height in meters squared (kg/m 2 ). General overweight and obesity were defined using BMI. Individuals with normal weight were defined as BMI<25 kg/m 2 . Overweight was defined as BMI≥25 and <30 kg/ m 2 . Obesity was defined as BMI≥30 kg/ m 2 . WC was measured in the upright position midway between the iliac crest and the lower costal margin. Sexspecific central/abdominal overweight and obesity were defined from WC. Individuals with no central obesity were defined as WC<80 cm for women and WC<94 cm for men. For women, central overweight was defined as WC≥80 cm and <88 cm and central obesity as WC≥88 cm. The central overweight definitions for men were a WC≥94 cm and <102 cm and WC≥102 cm for central obesity (as previously described in Bille et al 14 )
. Individuals had their blood pressure measured twice in the supine position after 5 minutes of rest, and the mean was subsequently calculated. Blood samples were drawn in the morning after a 12-hour overnight fast. Detailed description of assays has been published. 
Lifestyle Measures
Diet, alcohol consumption, physical activity, and smoking, which are used for interaction analyses, were all estimated from self-reported questionnaire data. A 3-point dietary score was developed based on a validated food frequency questionnaire. 17 In short, the dietary score was based on questions on the intake of fruits, raw, and boiled vegetables, vegetarian dishes, fish, and fat (both spread on bread and for preparation) to get a rough index of the overall quality of dietary habits, which were divided into 3 categories: (1) unhealthy, (2) moderately healthy, and (3) healthy. The participants were asked to report their average weekly intake of regular beer, strong alcoholic beer, wine, dessert wine, and spirits. The reported total intake of alcoholic beverages per week was calculated into units of ethanol (1 U=12 g). The level of physical activity was self-reported by questionnaire 18 and divided into categories as physically passive, light, or medium physically active, and hard or very hard physically active. Smoking habits were divided into 4 classes: (1) habitual/daily smoker, (2) occasional smoker, (3) former smoker, and (4) nonsmoker.
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Genotyping and SNP Selection
The SNPs were selected based on a meta-analysis of 46 genomewide association studies 6 and a recently published genome-wide association studies 5 that have confirmed 157 loci associating with circulating fasting levels of TC, LDL-C, HDL-C, or triglycerides at genome-wide significance (P<5×10 -8 ).
A total of 6377 individuals from Inter99 and 2883 individuals from Health2006 were genotyped using the Cardio-Metabochip 20 and Human Exome BeadChip on an Illumina HiScan system (Illumina, San Diego, CA). Genotypes were called using the Genotyping module (version 1.9.4) of GenomeStudio software (version 2011.1; Illumina) and custom cluster data generated from 5865 Danish DNA samples analyzed on the same Illumina HiScan. Individuals were excluded during quality control removing closely related individuals, individuals with an extreme inbreeding coefficient, individuals with a low callrate <90%, individuals with a mislabeled sex, and individuals with a high discordance rate to previously genotyped SNPs, leaving 6041 (5961 after removing individuals on lipid-lowering treatment) individuals from Inter99 and 2804 (2565 after removing individuals on lipid-lowering treatment) individuals from Health2006 who passed all quality control criteria. The average call-rate for all SNPs was 99.0% on both the Cardio-Metabochip and the Human Exome BeadChip.
Genotypes or proxies (r 2 >0.80) for the 157 loci associated with circulating fasting levels of TC, LDL-C, HDL-C, or triglycerides levels were retrieved from Cardio-Metabochip data or Human Exome BeadChip (Tables II-V in the Data Supplement) . Of the previously identified lipid risk SNPs, 1 variant (CTF1 rs11649653) was not present on any of the arrays and the locus was not captured by any proxies. Hence, we included 156 loci, of which 28 were proxies (r 2 >0.80; Tables II-V in the Data Supplement). Proxy search was performed based on HapMap and 1000 Genomes Pilot 1 data for linkage disequilibrium estimation using SNP annotation proxy search (http://www.broadinstitute.org/mpg/snap/).
The quality of SNPs was estimated by the genotyping call-rate (>95%), and Hardy-Weinberg equilibrium (>0.0003) or cross-hybridization with the X-chromosome, and all SNPs passed these filters (call-rate; min, 99.3%; max, 99.9%).
Genetic Risk Scores
The effect of multiple genetic risk loci was studied by constructing a wGRS for each study participant. A risk allele was defined as the allele associated with increased levels of fasting TC, LDL-C, or triglycerides or decreased fasting HDL-C levels. The wGRS was created as previously described by Renstrom et al. 21 We used reported effect sizes 5 for each SNP to weigh the contribution of each risk allele. Proxies were weighted using the reported effect sizes for lead SNPs because these reflect the same signal (Tables II-V in the Data Supplement). The weighted alleles were subsequently summed into a single score (wGRS). The wGRS of each individual was divided by the possible maximum wGRS and multiplied by the maximum number of risk alleles. Analyses were performed using the wGRS on a continuous scale.
Statistical Analyses
The statistical analyses were performed using the statistical software R, version 2.13.2 (http://www.r-project.org/). Linear regression models were used to test for associations between the single SNPs and the wGRS and quantitative lipid measures. Analyses were performed assuming an additive genetic model for single SNPs, and the wGRS was modeled as a continuous trait.
We tested the main effects in a model with wGRS and nongenetic risk factors, adjusted for age and sex. Values of serum triglycerides and HOMA-IR were logarithmically transformed to approach a normal distribution. In Inter99, the proportion of interindividual variance in the 4 lipid traits explained by genetic variants was assessed by the partial R 2 from linear regression models. The SNPs were entered both as individual covariates and as the combined wGRS in the model for the 4 lipid traits (74 TC, 58 LDL-C, 71 HDL-C, and 39 triglycerides variants, respectively). We tested the added variance explained by the interaction by comparing R 2 from the following 2 models (factor: BMI or WC):
Outcome age sex factor wGRS Interaction analyses were performed in the discovery Inter99 cohort. Given the number of interactions examined (diet, alcohol consumption, smoking, physical activity, BMI, WC, and HOMA-IR), Results for triglycerides and HOMA-IR are given in % because of a skewed distribution, which required log transformation before analysis. Analyses are adjusted for age and sex. BMI indicates body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; LDL, low-density lipoprotein; and wGRS, weighted genetic risk scores.
*Primary association between wGRS and the respective lipid trait.
we corrected for multiple testing using Bonferroni correction leading to a statistical significance threshold of 0.05/7=0.007. Significant interaction results were then analyzed in Health2006. We pooled β coefficients and SE from the interaction analyses from the Inter99 and Health2006 using the package meta and forest.meta in R, version 2.13.2. In the absence of heterogeneity in the interaction effects (I 2 <0.25%) between the 2 studies, the fixed-effect model was applied to the meta-analyses. This method combines studies under the assumption of a common genetic effect.
Results
All analyses were performed using the Inter99 cohort as discovery study and Health2006 as subsequent replication study. Sex distribution, age, BMI, WC, and lipid profile were comparable between the 2 cohorts ( Table I in 
Association Between wGRS and Lipid Levels
The wGRS for TC (mean, 75; range, 56-94 risk alleles), LDL-C (mean, 55; range, 38-72 risk alleles), HDL-C (mean, 63; range, 42-86 risk alleles), and triglycerides (mean, 75; range, 56-94 risk alleles) were strongly associated with 0.027 mmol/L per unit increased levels of fasting serum TC (P=1.1×10 ), respectively (Table 1) . Accordingly, we found similar results for both the Health2006 replication cohort (Table 1 ) and for analyses in Inter99 of men and women, separately (Table VI in To examine if whether wGRSs associated with additional metabolic traits, we analyzed the 4 wGRSs in relation to all lipid measures and other metabolic traits, such as BMI, WC, systolic blood pressure, diastolic blood pressure, or an estimate of insulin resistance (HOMA-IR; Table 1 ). Overall, the TC and LDL-C wGRSs both associated with levels of TC and LDL-C. The same tendency was observed for the HDL-C and triglycerides wGRSs that also both associated with serum HDL-C and triglycerides (Table 1) . However, the associations of the wGRSs were restricted to lipid levels. A suggestive association of the triglycerides wGRS with systolic blood pressure (−0.07 mm Hg; P=0.004) was observed in the discovery cohort, but this finding was not replicated in the Health2006 cohort (0.004 mm Hg; P=0.91; Table 1 ). Furthermore, the HDL-C wGRS associated with HOMA-IR in the Health2006 (0.003 mmol/L; P=0.004), but this association was marginally significant in the Inter99 cohort (0.001 mmol/L; P=0.06; Table 1 ).
Interactions Between wGRSs and Estimates of Metabolic Health and Lifestyle Factors
We tested whether the effect of the 4 wGRSs was modified by estimates of metabolic health such as BMI, WC, or HOMA-IR, respectively, or lifestyle factors such as diet, alcohol consumption, physical activity, or smoking. In the Inter99 discovery cohort, 3 metabolic health traits showed evidence of an interaction with the triglycerides wGRS in relation to fasting serum triglycerides levels; BMI (P interaction =0.002), WC (P interaction =0.0001), and HOMA-IR (P interaction =0.0005; Table 2 ). Thus, among individuals, who were more metabolically unhealthy (higher BMI and WC, and who were more insulin resistant), the triglycerides wGRS exerted a greater effect on fasting levels of serum triglycerides. In addition, we found an interaction between the HDL-C wGRS and physical activity (P interaction =0.00023; Table 2 ), suggesting that the HDL-C wGRS exerted a smaller effect in active individuals. We found no interactions between any wGRS and alcohol consumption, smoking or the dietary score (data not shown).
To strengthen the results, we aimed to replicate the significant results from the interaction analyses in the Health2006 cohort. Two of the suggestive interactions from Inter99 Analyses are adjusted for age and sex and BMI, waist circumference, HOMA-IR, or physical activity, respectively. HOMA-IR was logarithmically transformed before analysis.
BMI indicates body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; and wGRS, weighted genetic risk score.
were also significant in the Health2006 cohort; the triglycerides wGRS interactions with BMI (P interaction =0.02) and WC (P interaction =0.05; Table 3 ), whereas the interaction between triglycerides wGRS and HOMA-IR (P interaction =0.70) and HDL-C wGRS and physical activity (P interaction =0.86) was not replicated in the Health2006 cohort (Table 3) .
Performing meta-analyses on the 2 replicated interactions results increased the statistical significance of the interaction effects (triglycerides wGRS×BMI: P interaction =9. ), we observed a stepwise increasing effect of the triglycerides wGRS on fasting serum triglycerides levels with increasing BMI (Figure 2A and 2C) . The same stepwise increasing effect on fasting triglycerides levels was shown when we stratified individuals into groups based on WC ( Figure 2B and 2D ). The mean difference in triglycerides levels was significantly different for the obesity groups across the genetic risk groups. Hence, normal weight individuals in the first tertile of the wGRS had a geometric mean triglycerides In general, we found that women had lower fasting triglycerides levels compared with men. Interestingly, when we stratified the analyses based on sex, we found that the interacting effect of the wGRS was only significant among women in the Inter99 and not among men ( Table 4 ). The same tendency was observed in Health2006 (Table 4) .
Discussion
In the present cross-sectional study of middle-aged Danish individuals, we developed 4 wGRSs based on validated lipid loci for fasting levels of TC, LDL-C, HDL-C, and triglycerides to study the combined effect of multiple risk alleles. The 4 wGRSs all associated strongly with their respective primary traits in both the discovery Inter99 cohort and in the Health2006 replication cohort and the effects of the wGRSs were similar in both cohorts. The wGRSs were found to be exclusively associated with lipid measures and not with other metabolic traits, such as BMI, WC, systolic blood pressure, diastolic blood pressure, or HOMA-IR. Of interest, we report an interaction suggesting that obese individuals are more susceptible to the cumulative effect of genetic risk of having elevated fasting serum triglycerides level.
Genetic predisposition and the level of obesity are both known to increase the risk of having elevated fasting serum levels of triglycerides. Nevertheless, the triglycerides wGRS was neither associated with BMI nor WC but interestingly, the effect of the triglycerides wGRS was modulated by the individual BMI and WC level. Hence, the magnitude of the genetic effect estimate differs across the various BMI and WC groups. The common triglycerides genetic SNPs explain a modest proportion of the interindividual variability of fasting serum triglycerides level (4.8% in Inter99). It is likely that environmental factors exacerbate the genetic effect because individuals who have a higher genetic burden and are obese, have a nonadditively high value of fasting serum triglycerides. This interaction includes both overall obesity and abdominal obesity, and the interaction term adds an appreciable part to the explained variance (0.13% and 0.19% for interaction with BMI and WC, respectively). For comparison, when combined the SNPs most recently 5 identified only add 0.1% to the explained variance for serum triglycerides levels in the Inter99 population. Thus, we may find a proportion of the missing heritability from interactions. To further elucidate whether the observed interactions were affected by sex-specific fat distribution, we performed sex-stratified analyses and interestingly, these analyses indicated that the interactions were restricted to women suggesting a specific effect-modification of the female body composition. However, additional studies are warranted to investigate this putative influence of sex.
Because population-level genetic changes take many generations to occur, the rapidly increasing prevalence of dyslipidemia may be a consequence of recent environmental changes. The role of gene×lifestyle interactions has not been clarified. However, assessing more of such interactions may provide novel biological insight into disease pathways.
The major strengths of this study are the well-characterized discovery cohort used for these analyses and that we could replicate the 2 findings with similar interaction effect sizes in another Danish cohort.
In this study, we do not take single SNPs interactions or gene-gene interactions into account. Most likely, not all SNPs contribute to the modifying effect of the triglycerides wGRS and the effect could possibly be a consequence of only a single or a few modifying SNPs. It is critical that the lifestyle measures are reliable and of high quality. We did not find interactions of any wGRS with diet, alcohol consumption, smoking, or physical activity, which we were able to replicate. However, this study is based on self-reported questionnaires and the inaccuracy of these estimates may decrease statistical power for detecting interactions compared with the more precisely measured adiposity variables. Thus, based on this study, we cannot exclude that diet, alcohol consumption, smoking, or physical activity modulates the effect of genetic risk for elevated serum lipid levels. Large, statistically well-powered studies including, eg, objective measurements of physical activity will hopefully in the future help clarifying this. Also, our study included only Danish individuals and therefore the results may not apply to populations of other ethnicities.
Conclusions
We found that 4 cumulative wGRSs based on TC, LDL-C, HDL-C, and triglycerides risk loci were strongly associated with their respective fasting serum lipid trait in samples of the general Danish adult population. Of interest, we demonstrated that the effect of a wGRS based on 39 triglycerides SNPs was modified by measures of adiposity, suggesting that obese individuals are more susceptible to the genetic effect on fasting serum triglycerides levels. Therefore, particularly obese individuals with a high load of triglycerides increasing alleles may benefit from a targeted lifestyle intervention.
